4.4 Article

Antimicrobial blue light and photodynamic therapy inhibit clinically relevant 8-lactamases with extended-spectrum (ESBL) and carbapenemase activity

Related references

Note: Only part of the references are listed.
Review Microbiology

Epidemiology of beta-Lactamase-Producing Pathogens

Karen Bush et al.

CLINICAL MICROBIOLOGY REVIEWS (2020)

Article Infectious Diseases

Hypervirulent and hypermucoviscous strains of Klebsiella pneumoniae challenged by antimicrobial strategies using visible light

Carolina dos Anjos et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

Review Biochemistry & Molecular Biology

Light-based technologies for management of COVID-19 pandemic crisis

Caetano P. Sabino et al.

JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2020)

Review Chemistry, Medicinal

Photoinactivation of ESKAPE pathogens: overview of novel therapeutic strategy

Joanna Nakonieczna et al.

FUTURE MEDICINAL CHEMISTRY (2019)

Article Oncology

Inactivation kinetics and lethal dose analysis of antimicrobial blue light and photodynamic therapy

Caetano P. Sabino et al.

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2019)

Review Microbiology

Past and Present Perspectives on β-Lactamases

Karen Bush

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)

Review Infectious Diseases

Review: Molecular detection of extended spectrum-β-lactamase- and carbapenemase-producing Enterobacteriaceae in a clinical setting

Ineke G. H. Rood et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2017)

Article Microbiology

Mechanisms of Antibiotic Resistance

Jose M. Munita et al.

MICROBIOLOGY SPECTRUM (2016)

Review Microbiology

Carbapenems: Past, Present, and Future

Krisztina M. Papp-Wallace et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)

Review Microbiology

Extended-spectrum β-lactamases:: a clinical update

DL Paterson et al.

CLINICAL MICROBIOLOGY REVIEWS (2005)